Abiopharma

🔍 WILLS STEPHEN T (Executive)

Company: PALATIN TECHNOLOGIES INC (PTN)

Report Date: 2025-12-09

Detailed Transactions and Holdings:

• Acquired 95 shares of Common Stock (Direct)
  Date: 2025-12-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 63,378.00 | transaction_form_type: 4 | Footnotes: F1, F1
• Acquired 330 shares of Common Stock (Direct)
  Date: 2025-12-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 63,708.00 | transaction_form_type: 4 | Footnotes: F2, F2
• Acquired 345 shares of Common Stock (Direct)
  Date: 2025-12-09 | Code: A | equity_swap_involved: 0 | shares_owned_after: 64,053.00 | transaction_form_type: 4 | Footnotes: F3, F3
• Acquired 142 shares of Stock Option (Right to Buy) at $362.5 per share (Derivative)
  Date: 2025-12-09 | Code: A | Expires: 2032-06-22 | Exercise: 2025-12-09 | equity_swap_involved: 0 | shares_owned_after: 121,900.00 | transaction_form_type: 4 | Footnotes: F4
• Acquired 518 shares of Stock Option (Right to Buy) at $109.5 per share (Derivative)
  Date: 2025-12-09 | Code: A | Expires: 2033-06-20 | Exercise: 2025-12-09 | equity_swap_involved: 0 | shares_owned_after: 122,418.00 | transaction_form_type: 4 | Footnotes: F5
• Acquired 495 shares of Stock Option (Right to Buy) at $91.5 per share (Derivative)
  Date: 2025-12-09 | Code: A | Expires: 2034-06-04 | Exercise: 2025-12-09 | equity_swap_involved: 0 | shares_owned_after: 122,913.00 | transaction_form_type: 4 | Footnotes: F6

Footnotes:

• F1: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The performance condition grant, made June 22, 2022, vested in part on December 9, 2025, upon certification by the Compensation Committee of a defined performance objective as to 100% of the target number of share units for the 18 months ending December 31, 2025. The shares have not been issued as of the date of this Form 4, but will be issued on or before the 60th day following December 9, 2025.
• F2: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The performance condition grant, made June 20, 2023, vested in part on December 9, 2025, upon certification by the Compensation Committee of a defined performance objective as to 100% of the target number of share units for the 18 months ending December 31, 2025. The shares have not been issued as of the date of this Form 4, but will be issued on or before the 60th day following December 9, 2025.
• F3: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The performance Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The performance condition grant, made June 4, 2024, vested in part on December 9, 2025, upon certification by the Compensation Committee of a defined performance objective as to 100% of the target number of share units for the 18 months ending December 31, 2025. The shares have not been issued as of the date of this Form 4, but will be issued on or before the 60th day following December 9, 2025.
• F4: Performance-based stock options granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, upon payment of the exercise price, one share of common stock. The performance condition stock option grant, made June 22, 2022, vested in part on December 9, 2025, upon certification by the Compensation Committee of a defined performance objective as to 100% of the target number of share units for the 18 months ending December 31, 2025.
• F5: Performance-based Stock options granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, upon payment of the exercise price, one share of common stock. The performance condition stock option grant, made June 20, 2023, vested in part on December 9, 2025, upon certification by the Compensation Committee of a defined performance objective as to 100% of the target number of share units for the 18 months ending December 31, 2025.
• F6: Performance-based stock options granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, upon payment of the exercise price, one share of common stock. The performance condition stock option grant, made June 4, 2024, vested in part on December 9, 2025, upon certification by the Compensation Committee of a defined performance objective as to 100% of the target number of share units for the 18 months ending December 31, 2025.